NRX Pharmaceuticals Receives FDA Fast Track for NRX-100, Eyes Financial Turnaround
NRX Pharmaceuticals Inc. has gained significant attention after receiving FDA Fast Track designation for its investigational drug NRX-100, which aims to treat suicidal ideation in patients with depression.
2 minutes to read